BioSpace News Archive

Cagent Vascular, the exclusive developer of serration technology for vessel dilatation in endovascular interventions, announced the results of its Below-the-Knee RECOIL study.

What began as a specialization in glaucoma therapeutics has become a launchpad for developing new fibrotic and vascular 3D human tissue models.

PharmaJet,® a company engineering Precision Delivery Systems™ that overcome the challenges of vaccines and pharmaceuticals delivery, announced that Nanette Cocero, Ph.D., has been appointed to its Board of Directors.

Achieve Life Sciences, Inc. (NASDAQ: ACHV), today announced the publication in JAMA of the results from the Phase 3 ORCA-2 randomized placebo-controlled clinical trial of cytisinicline as a treatment for smoking cessation, the first large trial of this medication conducted in the United States.

Abivax SA (Euronext Paris: FR0012333284 - ABVX), a Phase 3 clinical-stage biotechnology company focused on developing therapeutics that modulate the immune system to treat patients with chronic inflammatory diseases, announces today the appointment of June Lee, M.D. and Troy Ignelzi as new independent members of the Abivax Board of Directors.

Novel patient-led research initiative will measure the true impact of skin diseases globally

Clearside Biomedical, Inc. announced that George Lasezkay, Pharm.D., J.D., Clearside’s President and Chief Executive Officer, will present at the SHARE™ Series Monday Management Update for investors on Monday, July 17, 2023, at 11:30 am ET.

CytoDyn Inc. announced that it has filed a supplemental Statement of Claim and formally requested a hearing date in its litigation proceeding against Amarex Clinical Research LLC, the Company’s former Contract Research Organization.

Azitra, Inc., a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, announced the appointment of Travis Whitfill as Chief Operating Officer.

Centene Corporation, a leading healthcare enterprise committed to helping people live healthier lives, announced it has received a top score of 100% in the 2023 Disability Equality Index®, a comprehensive benchmarking tool that measures disability inclusion in the workplace.